#gramnegativebacteria — Public Fediverse posts

Lolamicin: The Selective antibiotic against Gram-negative infections that spares gut microbiome  
Current antibiotics used in clinical practice, in addition to neutralising target pathogens also harm healthy bacteria in the gut............
#Antibiotics #Gramnegativebacteria #GutBacteria #Lolamicin #microbiome #NewsinBrief
SCIEU Team

https://www.scientificeuropean.co.uk/medicine/lolamicin-the-selective-antibiotic-against-gram-negative-infections-that-spares-gut-microbiome/

Lolamicin: The Selective antibiotic against Gram-negative infections that spares gut microbiome  
Current antibiotics used in clinical practice, in addition to neutralising target pathogens also harm healthy bacteria in the gut............
#Antibiotics #Gramnegativebacteria #GutBacteria #Lolamicin #microbiome #NewsinBrief
SCIEU Team

https://www.scientificeuropean.co.uk/medicine/lolamicin-the-selective-antibiotic-against-gram-negative-infections-that-spares-gut-microbiome/

Lolamicin: The Selective antibiotic against Gram-negative infections that spares gut microbiome  
Current antibiotics used in clinical practice, in addition to neutralising target pathogens also harm healthy bacteria in the gut............
#Antibiotics #Gramnegativebacteria #GutBacteria #Lolamicin #microbiome #NewsinBrief
SCIEU Team

https://www.scientificeuropean.co.uk/medicine/lolamicin-the-selective-antibiotic-against-gram-negative-infections-that-spares-gut-microbiome/

Lolamicin: The Selective antibiotic against Gram-negative infections that spares gut microbiome  
Current antibiotics used in clinical practice, in addition to neutralising target pathogens also harm healthy bacteria in the gut............
#Antibiotics #Gramnegativebacteria #GutBacteria #Lolamicin #microbiome #NewsinBrief
SCIEU Team

https://www.scientificeuropean.co.uk/medicine/lolamicin-the-selective-antibiotic-against-gram-negative-infections-that-spares-gut-microbiome/

Lolamicin: The Selective antibiotic against Gram-negative infections that spares gut microbiome  
Current antibiotics used in clinical practice, in addition to neutralising target pathogens also harm healthy bacteria in the gut............
#Antibiotics #Gramnegativebacteria #GutBacteria #Lolamicin #microbiome #NewsinBrief
SCIEU Team

https://www.scientificeuropean.co.uk/medicine/lolamicin-the-selective-antibiotic-against-gram-negative-infections-that-spares-gut-microbiome/

Scientists hail new antibiotic that can kill drug-resistant bacteria | Infectious diseases | The Guardian
https://www.theguardian.com/science/2024/jan/03/scientists-new-class-antibiotic-kill-drug-resistant-bacteria

#Antibiotic
#DrugResistantBacteria
#NewAntibiotic
#Zosurabalpin
#Sepsis
#LPS
#Lipopolysaccharide
#GramNegativeBacteria

Scientists hail new antibiotic that can kill drug-resistant bacteria | Infectious diseases | The Guardian
https://www.theguardian.com/science/2024/jan/03/scientists-new-class-antibiotic-kill-drug-resistant-bacteria

#Antibiotic
#DrugResistantBacteria
#NewAntibiotic
#Zosurabalpin
#Sepsis
#LPS
#Lipopolysaccharide
#GramNegativeBacteria

Scientists hail new antibiotic that can kill drug-resistant bacteria | Infectious diseases | The Guardian
https://www.theguardian.com/science/2024/jan/03/scientists-new-class-antibiotic-kill-drug-resistant-bacteria

#Antibiotic
#DrugResistantBacteria
#NewAntibiotic
#Zosurabalpin
#Sepsis
#LPS
#Lipopolysaccharide
#GramNegativeBacteria

Scientists hail new antibiotic that can kill drug-resistant bacteria | Infectious diseases | The Guardian
https://www.theguardian.com/science/2024/jan/03/scientists-new-class-antibiotic-kill-drug-resistant-bacteria

#Antibiotic
#DrugResistantBacteria
#NewAntibiotic
#Zosurabalpin
#Sepsis
#LPS
#Lipopolysaccharide
#GramNegativeBacteria

The structure of this endolysin targeting Gram-negative bacteria will contribute to the development of alternative therapeutic agents for the treatment of multidrug-resistant bacteria. #GramNegativeBacteria #Endolysins #AntibacterialAgents https://doi.org/10.1107/S2053230X23002583

The structure of this endolysin targeting Gram-negative bacteria will contribute to the development of alternative therapeutic agents for the treatment of multidrug-resistant bacteria. #GramNegativeBacteria #Endolysins #AntibacterialAgents https://doi.org/10.1107/S2053230X23002583

Jee-Min Wang et al.: Crystal structure of the engineered endolysin mtEC340M #GramNegativeBacteria #Endolysins #AntibacterialAgents ... #IUCr http://scripts.iucr.org/cgi-bin/paper?S2053230X23002583

Jee-Min Wang et al.: Crystal structure of the engineered endolysin mtEC340M #GramNegativeBacteria #Endolysins #AntibacterialAgents ... #IUCr http://scripts.iucr.org/cgi-bin/paper?S2053230X23002583